- Home
- NEO vs AMBQ Comparison
NEO vs AMBQ Comparison
Compare NEO & AMBQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- AMBQ
- Stock Information
- Founded
- NEO 2001
- AMBQ 2010
- Country
- NEO United States
- AMBQ United States
- Employees
- NEO N/A
- AMBQ N/A
- Industry
- NEO Precision Instruments
- AMBQ Semiconductors
- Sector
- NEO Health Care
- AMBQ Technology
- Exchange
- NEO Nasdaq
- AMBQ Nasdaq
- Market Cap
- NEO 709.2M
- AMBQ 673.1M
- IPO Year
- NEO 1999
- AMBQ 2025
- Fundamental
- Price
- NEO $6.61
- AMBQ $38.42
- Analyst Decision
- NEO Buy
- AMBQ
- Analyst Count
- NEO 8
- AMBQ 0
- Target Price
- NEO $12.00
- AMBQ N/A
- AVG Volume (30 Days)
- NEO 3.0M
- AMBQ 860.9K
- Earning Date
- NEO 07-29-2025
- AMBQ 09-04-2025
- Dividend Yield
- NEO N/A
- AMBQ N/A
- EPS Growth
- NEO N/A
- AMBQ N/A
- EPS
- NEO N/A
- AMBQ N/A
- Revenue
- NEO $689,189,000.00
- AMBQ $76,589,000.00
- Revenue This Year
- NEO $13.83
- AMBQ N/A
- Revenue Next Year
- NEO $11.35
- AMBQ N/A
- P/E Ratio
- NEO N/A
- AMBQ N/A
- Revenue Growth
- NEO 9.70
- AMBQ 50.25
- 52 Week Low
- NEO $4.72
- AMBQ $32.89
- 52 Week High
- NEO $19.12
- AMBQ $51.76
- Technical
- Relative Strength Index (RSI)
- NEO 58.15
- AMBQ N/A
- Support Level
- NEO $5.94
- AMBQ N/A
- Resistance Level
- NEO $6.35
- AMBQ N/A
- Average True Range (ATR)
- NEO 0.26
- AMBQ 0.00
- MACD
- NEO 0.12
- AMBQ 0.00
- Stochastic Oscillator
- NEO 99.20
- AMBQ 0.00
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.